How Antimicrobial Resistance Threatens Neonatal Mortality Rates Globally
Neonatal mortality remains a major health challenge across the world, which involves neonatal sepsis and other related factors of prematurity. Though many strides have been done in reducing NMR, there is a need for more appropriate interventions and strategies directed towards addressing the rise in the escalation of AMR. Combating AMR will be critical in improving neonatal survival rates while giving each newborn a healthier start into life globally.
The newborn period is the key period for infant health, and the first 28 days of life are critically important-both for survival and as a base to set lifetime health and development. Neonatal deaths globally have witnessed a significant decline over the past couple of decades. The neonatal mortality count has significantly reduced dropping from a high of 5 million in 1990 to as low as 2.3 million as of 2022. However, this decline notwithstanding, neonatal mortality is still staggeringly high across low-and middle-income nations.
Neonatal mortality rates are 22 per 1000 live births in India. Neonatal sepsis and prematurity are the main causes of neonatal deaths in these tragic events. Recognizing the gravity of the issue the Indian government started the Indian Newborn Action Plan (INAP) in 2014. The goal is to take NMR down to the single digits by 2030. This initiative has brought in several key interventions, including antenatal care (vaccines, micronutrient supplementation), skilled birth attendance, clean birth practices, and neonatal resuscitation techniques. More promisingly, postnatal interventions, including early initiation of breastfeeding and skin-to-skin contact, have been proven to work well in improving newborn survival rates.
Despite these improvements, one of the biggest concerns in neonatal care today is the growing problem of antimicrobial resistance (AMR) which seriously threatens efforts to reduce neonatal mortality.
Antimicrobial resistance occurs when microorganisms such as bacteria, viruses and fungi evolve over time and become resistant to commonly used antibiotics and other medications. This resistance makes infections more difficult to treat, increasing the risk of mortality and complicating treatment options. The World Health Organization has classified AMR as one of the most urgent global health threats since it not only causes death and disability but also places immense pressure on healthcare systems, significantly raising the economic burden.
The sources of AMR are many, including poor hygiene and infection control in healthcare settings, overuse and misuse of antibiotics. Contributing factors to this rapidly growing problem are antibiotic prescriptions for patient needs that do not require them and failure to complete antibiotic courses, as prescribed.
For neonates, the risk is much more vital for AMR. Neonates are particularly prone to developing infections due to their rather weak immune systems. Neonatal sepsis, severe bacterial infection, is one of the leading causes of neonate deaths and it often manifests complications when it is because of drug-resistant pathogens.
According to Dr. Apoorva Taduri, Consultant Neonatologist, "Neonatal sepsis accounts for a significant proportion of neonatal deaths, and AMR is making it worse. MDR pathogens cause around 30% of neonatal sepsis mortality globally.
Maternal health and care are also factors influencing AMR in neonates. Over-prescription of antibiotics during pregnancy increases the risk of neonatal sepsis and the development of multi-drug-resistant pathogens in newborns. This calls for prudent use of antibiotics during pregnancy and at the time of delivery. In fact, studies indicate that indiscriminate use of antibiotics in mothers has a direct impact on neonatal health, which may eventually lead to resistant infections in newborns.
One of the major issues is that the drug-resistant bacteria are causing an increasing number of healthcare-associated infections in the neonatal care settings, which include NICUs. Infections by such bacteria prove to be challenging to treat; they require more advanced, expensive interventions, and the period of risk of mortality and morbidity is extended.
To combat AMR and reduce neonatal mortality a multifaceted approach is necessary. Dr. Taduri emphasizes the continuation of the strategies outlined by the Indian Newborn Action Plan (INAP), specifically in reducing neonatal sepsis and improving infection control. However, to combat AMR more must be done to ensure proper use of antibiotics in both maternal and neonatal care settings.
Key strategies for reducing AMR in neonatal care are:
1. Improving Infection Prevention Practice: This implies, therefore, that more efforts would be made regarding stricter hospital hygiene standards, strict equipment sterilization after its usage and even maintaining adequate hand hygiene. Enhanced infection control practices greatly impact minimizing AMR pathogens distribution.
2. Antibiotic Stewardship- Teaching the healthcare providers how not to use antibiotics is a crucial thing in preventing overuse prescription. Antibiotic stewardship programs are designed to promote use of antibiotics only when truly required; appropriate drug, dose and length of treatment should be taken.
3. Improved access to WASH: Access to clean water and sanitation is a fundamental aspect of preventing infections in mothers and newborns. WASH interventions such as clean birthing practices, can reduce the risk of neonatal sepsis due to unsanitary conditions.
4. Maternal Health Strengthening: Proper maternal care, such as proper vaccination, antenatal steroids, and supplementation of micronutrients, can reduce the risk of prematurity and neonatal infection. Prevention of infection in mothers is the first step towards prevention of infection in newborns.
5. Early Diagnosis and Treatment: Early identification and treatment of neonatal infections are very important. This includes proper screening for sepsis and the use of appropriate antibiotics based on the local resistance patterns. It also involves ensuring that infants receive adequate neonatal care, such as those provided in Special Newborn Care Units (SNCUs).
The rise of antimicrobial resistance is a global health challenge that requires urgent action. Combating AMR requires a coordinated effort from governments, healthcare systems and communities worldwide. In neonatal care, addressing AMR is essential to further reducing neonatal mortality rates and ensuring that every newborn has the opportunity to thrive.
As Dr. Taduri concludes, "While we have made substantial progress in reducing neonatal mortality, the emerging risk of antimicrobial resistance creates a major challenge for our efforts. Combating AMR requires a global collective effort, with priorities on infection prevention, responsible use of antibiotics, and enhancement of healthcare practices to ensure a healthier future for all newborns."
Dr Apoorva Taduri is a Consultant Neonatologist at Fernandez Hospital
Credit: X
Massachusetts is moving to strengthen postpartum mental-health care after the controversial trial of Lindsay Clancy increased focus on gaps in treating serious mental-health conditions during and after pregnancy.
Governor Maura Healey has proposed $2 million to expand voluntary nurse home visits to families with newborns, along with $250,000 to strengthen a state program that helps healthcare providers identify and treat mental-health and substance-abuse problems during pregnancy and after birth.
The state's Department of Public Health will also update regulations governing perinatal mental-health screening to identify a broader range of conditions, including mood and anxiety disorders and postpartum psychosis.
The current Massachusetts law already requires postpartum depression or major depressive disorder screening for eligible postnatal individuals receiving care from primary-care providers, obstetricians, midwives and pediatricians.
But mental health problems after pregnancy can extend beyond depression.
The state's updated approach is expected to give healthcare providers more opportunities to ask about a patient's mental health during and after pregnancy, including during visits with an obstetrician, primary-care doctor or pediatrician.
Healey said, “Becoming a mother is a profound life change, and every parent deserves support — not just during pregnancy, but in the months that follow.”
She added, “Postpartum depression, anxiety and other maternal mental health conditions are real medical conditions, and no mother should feel ashamed to ask for help or feel like she has to navigate this journey alone.”
The changes are particularly relevant because there is currently no validated screening tool specifically for postpartum psychosis. Massachusetts health guidance says diagnosis depends on a healthcare provider assessing the person's symptoms.
Also read: The Postpartum Nutrition Gap: Why New Mothers Often Neglect Their Own Health After Delivery
The proposed $2 million investment would expand the state's Welcome Family programme so that all families with newborns can be offered a voluntary nurse home visit.
Massachusetts has around 68,000 births a year, while the programme currently reaches about 3,000 families annually. During a visit, a nurse can assess the health of the mother and baby, answer questions about feeding and sleep, and connect families with additional support.
The state also plans to invest $250,000 in the Massachusetts Child Psychiatry Access Program for Moms, which supports healthcare providers treating maternal mental health and substance-use conditions.
The additional funding could also help track postpartum psychosis data and improve education for healthcare professionals, mothers and families about warning signs.
Perinatal mental-health conditions can affect people during pregnancy and after childbirth. Depression and anxiety are more common, while postpartum psychosis is rare but requires urgent medical attention.
Massachusetts' move aims to ensure that mental-health concerns are not identified only during a dedicated postpartum visit, but also when new parents interact with other parts of the healthcare system.
The measures follow the trial of Lindsay Clancy, whose attorneys argued that she experienced postpartum psychosis when she killed her three children in 2023. Prosecutors disputed the defence's argument, and the jury ultimately failed to reach a unanimous verdict, resulting in a mistrial.
Healey said the bigger goal is to make conversations about maternal mental health more routine. She said, “To every mom who has struggled with her mental health before, during or after pregnancy, I want you to know we see you — I see you.”
Credit: AI
A 54-year-old woman in Greece recently gave birth to a healthy baby girl using an embryo that had been frozen for more than two decades. The case has marked a milestone in IVF, raising an intriguiging question: does a frozen embryo eventually have an expiry date?
Cristina Rapti-Tzelepi and her husband, Constantinos Raptis, welcomed their daughter Georgia in Athens on September 9.
The embryo was originally cryopreserved in March 2004 and was transferred in December 2025. The baby weighed 3.49 kg at birth.
The couple decided to use one of their remaining embryos after their 21-year-old son, Giorgos, died in a road accident in October 2025. Their son had also been born following IVF using an embryo from the same original treatment.
The case is remarkable as the embryo remained frozen for more than two decades. But scientifically, that does not mean the embryo continued ageing for 22 years.
A frozen embryo does not age in the way a an actual human person does. During cryopreservation, embryos are stored at extremely low temperatures, generally around -196°C in liquid nitrogen. At this temperature, biological processes that drive cellular ageing effectively stop.
The key is maintaining stable cryostorage conditions. The American Society for Reproductive Medicine says cryopreserved embryos must be maintained under stringent conditions, with IVF laboratories monitoring liquid-nitrogen levels and storage systems.
So, an embryo frozen in 2004 does not biologically become a 22-year-old embryo. Its chronological storage time increases, but its cells are preserved in the state they were in when frozen.
A recent systematic review and meta-analysis published in Human Reproduction Open examined 23 studies involving more than 250,000 embryo-transfer cycles.
Researchers found that embryos stored for longer than five years appeared slightly less likely to survive thawing, with some reductions in pregnancy and live-birth rates.
However, the outcomes stopped worsening after around two years of storage, with no further deterioration as storage continued for much longer periods.
Longer storage was also not associated with increased risks of premature birth, high birth weight, or birth defects.
Earlier research has similarly found no dose-response relationship between the duration of embryo cryostorage and pregnancy outcomes.
Also read: Explained: What Is Posthumous Reproduction?
Scientifically, there is no established biological expiry date for a properly cryopreserved embryo. The bigger concerns are the quality of the embryo before freezing, the freezing and thawing technique, laboratory conditions, and whether the embryo survives thawing.
There are also factors like biological limits and legal limits that affect IVF. In Greece, women currently have a legal age limit of 54 for completing IVF procedures.
Rapti-Tzelepi had only a limited window in which to obtain approval and undergo treatment. Her case is therefore not proof that every embryo can remain viable indefinitely. But it provides another striking example of how modern cryopreservation can preserve reproductive potential for decades.
Credit: iStock
Nearly 76,805 children and adolescents in India are estimated to develop cancer each year. At the same time, childhood cancer can be highly treatable when diagnosed early and managed appropriately, with survival exceeding 80% in settings where timely diagnosis and comprehensive treatment are available.
When people think about preventive healthcare for children, the conversation usually centers on vaccinations, good nutrition, physical activity, sleep and regular health check-ups. These are important for a child’s overall health. But prevention also involves something that is often overlooked: recognizing when a child’s health is changing and seeking medical advice at the right time.
Childhood cancer is different from many cancers seen in adults. In most cases, there is no clear lifestyle-related cause that parents could have avoided. A child developing cancer is therefore not usually linked to something the parents did or did not do. This is important because there is no particular diet, exercise routine or supplement that can guarantee protection against childhood cancer.
For doctors, one of the more practical ways to improve outcomes is to recognize when a seemingly common symptom is not following its usual course. Fever, tiredness, headaches, loss of appetite or body pain are frequent childhood complaints. But when they persist, keep returning or occur alongside other changes, they should not simply be treated repeatedly without evaluation.
• Unexplained weight loss
• Unusual bruising or bleeding
• Persistent bone or abdominal pain
• A growing lump or swelling
• Repeated headaches
• Changes in vision
These are some signs that may require further assessment. These symptoms are not specific to cancer, but their persistence warrants attention.
Most childhood cancers do not have a routine screening test for healthy children. Diagnosis therefore often depends on noticing an unusual pattern and investigating it appropriately.
A delay does not necessarily mean that cancer has been missed, but prolonged delays can allow some cancers to progress before treatment begins. For this reason, awareness among parents and healthcare providers, timely evaluation and appropriate referral are important parts of childhood cancer care.
Prevention Is Not Just About Avoiding Cancer
Vaccination still has a place in the broader cancer-prevention conversation. Hepatitis B vaccination helps reduce the risk of liver cancer linked to chronic hepatitis B infection, while HPV vaccination can help prevent HPV-related cancers later in life. However, these vaccines do not prevent most cancers that occur during childhood.
Similarly, nutrition should be viewed in the right context. A balanced diet supports growth and recovery, including during cancer treatment, but there is no specific food or diet that can prevent a cancer.
Childhood cancer can place a significant financial and practical burden on families. Treatment costs may be accompanied by expenses related to travel, accommodation, food and time away from work.
At the same time, families today have more avenues of support than before. Government health schemes, public healthcare facilities and non-government organizations can help with treatment costs and other practical needs. The challenge is ensuring that families are aware of these resources and can access them early enough.
Children who survive cancer may need long-term monitoring for possible effects of treatment on growth, development and other aspects of health.
For childhood cancer, therefore, prevention is less about finding a way to eliminate risk and more about reducing what can be changed: delayed diagnosis, interruptions in treatment and avoidable long-term complications..
(Dr Amita Mahajan, Senior Consultant, Pediatric Oncology, Indraprastha Apollo Hospital, Delhi)
© $2026 Times Horizon Private Limited